Jun Wang, Ph.D.

Assistant Professor, Department of Pathology at NYU Grossman School of Medicine

Speaker

Dr. Jun Wang is currently an Assistant Professor of Pathology at NYU Grossman School of Medicine. Dr. Wang possesses around two decades of expertise in immunotherapy, focusing on the discovery of novel immune receptor-ligand pathways and their utilization for treating cancer and autoimmune diseases. In addition to his early experience with anti-4-1BB immunotherapy, he has characterized FGL1/LAG-3, Siglec-15, MHC-I membrane inhibitors, SARS-CoV-2 myeloid receptors, immune feedback modulators etc., as potential mechanisms of immune evasion and targets for immunotherapy. He is the founder and scientific advisor for Remunix Inc., an advisor for BMS, Hanmi, Regeneron, an advisor and scientific co-founder for Rootpath Genomics, and a co-founder of BioSpark Group.